Navigation Links
Hadasit Bio-Holdings CEO Letter to Shareholders
Date:4/9/2013

l Industrial Research and Development (BIRD) Foundation to support BioMarCare's partnership with Ariadne Inc. (based in Florida).
  • The Israeli Office of the Chief Scientist (OCS) in the Ministry of Industry, Trade and Labor provided our companies with substantial grants totaling over $3M.
  • Over 5M NIS were raised from the public through a rights-offering with an outstanding participation of over 99% of eligible rights holders. Several leading Israeli institutional investors participated.
  • Hadasit Bio-Holdings Ltd. was one of the first Israeli biotech companies to establish an American Depositary Receipts (ADR) program exposing the TASE stock in a liquid and transparent manner to the American market. We are now 'Blue Sky' approved in over 30 states and the ADR holders have purchased over 2.5% of the outstanding TASE shares.
  • Thrombotech Ltd. was acquired by D-Pharm and we now hold ~14% of the publicly traded company.
  • Future Plans:

    Over the year we saw a substantial increase in the global interest in the growth potential of the Israeli biotechnology industry, and more specifically, an increase concerning HBL. We believe this growing interest in our Company was generated due to our unique model of a holding company that maintains a strong affinity for and involvement with a leading and innovative private hospital. In the coming year, we intend to take advantage of this interest by forging ties and building strategic partnerships with leading pharmaceutical entities, manufacturers and investors.

    With the ongoing maturation of the current portfolio companies, investment options in new and attractive companies are always being examined. In order to manage risk in the best possible way and thoroughly utilize the relative advantage HBL has as a holding company with a hospital in its 'back yard', we have developed an innovative business model for these potential investments. The model i
    '/>"/>

    SOURCE Hadasit Bio-Holdings Ltd.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
    2. KAHR Medical, a Hadasit Bio-Holdings Portfolio Company, to Raise $2.6 Million
    3. Hadasit Bio-Holdings Interviewed by Wall Street Reporter
    4. Hadasit Bio-Holdings Ltd. Portfolio Companies - ProtAb Ltd. and KAHR Medical Ltd. to Receive NIS 10.7 Million (Over $2.8 Million USD) in Additional Government Grants
    5. NeoStems CEO Letter to Shareholders
    6. Genesis Biopharma Issues Letter To Shareholders
    7. Bacterin Receives Letter From NYSE MKT LLC Regarding Timely Notice of Record Date for 2012 Annual Meeting of Stockholders
    8. Elsevier to Participate in SCOAP3 With the Journals Physics Letters B and Nuclear Physics B
    9. Ronald L. Chez Files Amended 13D and Letter to the Board
    10. Mangrove Partners Sends Letter to Stockholders of Nabi Biopharmaceuticals
    11. Amarantus BioSciences Issues CEO Letter to Shareholders
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/22/2015)... (PRWEB) January 22, 2015 Pipette.com has ... to their comprehensive portfolio of Eppendorf products. , ... to purchase a Centrifuge 5424/5424 R and receive the ... either Eppendorf Research plus or Eppendorf Reference 2 ...
    (Date:1/22/2015)... (PRWEB) January 22, 2015 Selexis SA, ... mammalian Research Cell Banks (RCBs) used for drug discovery ... Cell Banks will include Next-Generation Sequencing (NGS) ... architecture de-risks biologic manufacturing by ensuring the integrity of ...
    (Date:1/22/2015)... , Jan. 22. 2015  Varian Medical Systems (NYSE: ... been honored for its commitment to sustainability with inclusion on ... is the highest ranked healthcare equipment company among the Corporate ... the World Economic Forum at Davos, Switzerland ...
    (Date:12/24/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) announced ... has submitted a pre-market approval application to the U.S. ... Medtronic,s SynchroMed ® II implantable drug infusion system ... Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously to ...
    Breaking Biology Technology:Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
    ... , RESEARCH TRIANGLE PARK, N.C., July 22 ... it has completed its acquisition of Stiefel Laboratories, Inc. GSK has ... $2.9 billion. GSK also assumed $0.4 billion of net debt. ... additional cash payments of up to $0.3 billion depending on the future ...
    ... DUBAI, United Arab Emirates and SAN FRANCISCO, July 22 ... serving the Middle East, Africa, Turkey & Caspian regions, today ... supply agreement with Axcan Pharma for Pylera (R) , an ... pylori , a bacterium now recognized as being the main ...
    ... , CHICAGO, July 22 ... annual meeting today indicates that monitoring cardiac transplant patients with ... help clinicians to monitor cyclosporine-induced toxicity and adjust doses of ... , , In a scientific ...
    Cached Biology Technology:GlaxoSmithKline Completes Acquisition of Stiefel 2NewBridge Pharmaceuticals Announces Licensing of Pylera(R) for Middle East, Africa, Turkey & Caspian Region 2NewBridge Pharmaceuticals Announces Licensing of Pylera(R) for Middle East, Africa, Turkey & Caspian Region 3Investigational Urine NGAL Biomarker Shows Promise to Monitor Cyclosporine Toxicity in Cardiac Transplant Patients 2
    (Date:1/22/2015)... , Jan. 22, 2015   EyeLock, Inc. , a ... has appointed Steve Gerber to the new role ... be responsible for leading development of mobile platforms and wearable ... of success and innovation in the semiconductor industry to his ...
    (Date:12/24/2014)... , Dec. 23, 2014  Since its launch in December 2014, ... to eliminate the pain of trying to remember their usernames ... biometrics fused to their smartphones. To assist people who have ... the company that created 1U and focuses on redefining identity, ...
    (Date:12/22/2014)... and Markets ( http://www.researchandmarkets.com/research/fx4bg3/the_global ) has ... Watermarking and Fingerprinting Markets" report to their ... This insight provides an overview of ... Watermarking aims to control and monitor piracy by ...
    Breaking Biology News(10 mins):EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3The Global Watermarking and Fingerprinting Markets 2
    ... the familiar semi-aquatic bugs gliding across the lake at the ... walk on water. This was not always the case. ... unique arrangement of the legs, with the mid-legs greatly elongated. ... Evolutionary Biology have discovered the gene behind this evolutionary change. ...
    ... human brain distinctly separates the handling of images of ... image type in a different area of the brain. ... visual information in this manner to optimize processing the ... people who have been blind since birth the brain ...
    ... Sandbar, dusky and tiger sharks are among dozens of ... East Coast. Little is known about many of the species, ... scientists and fishery resource managers to monitor shark populations and ... Northeast Fisheries Science Center (NEFSC) lab in Narragansett, R.I., recently ...
    Cached Biology News:Brain innately separates living and non-living objects for processing 2Scientists conduct shark survey off US East Coast 2Scientists conduct shark survey off US East Coast 3
    Unique enzyme blend containing Taq and Pwo DNA Polymerase and another thermostable enzyme. The Expand 20 kbPLUS PCR System also includes an optimized reaction buffer, MgCl2 solution, and a human cont...
    ... Pfx DNA Polymerase is ideal for ... downstream applications such as cloning and ... by a proprietary enzyme preparation containing ... with proofreading (3'Cut Site5' exonuclease) activity. ...
    ... supply is a highly compact, extremely reliable and ... knob and one hi-lo range switch control the ... from 20 to 250 volts. One two-position switch ... voltage to output current. For maximum safety, the ...
    ... offers precision beveling of micropipette ... The unique abrasive plate drive ... greater control of the beveling ... very rapidly and produces consistent ...
    Biology Products: